GLYCOPYRRONIUM (Sialanar®)

Clinical Indication

Persistent drooling in children and adolescents with neurological conditions, such as cerebral palsy, epilepsy and neurodegenerative diseases

Comments

New formulation
Not yet reviewed

Date of classification

June 2017

Review date

June 2017

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.

All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry.